Status:
WITHDRAWN
Treatment of Severe Hypertension With ICG Directed Therapy
Lead Sponsor:
Marshall University
Conditions:
Hypertension in Pregnancy
Eligibility:
FEMALE
15-45 years
Phase:
NA
Brief Summary
The purpose of the study is to compare the usefulness of Impedence Cardiography (ICG) directed therapy in treating severe range hypertension in pregnant women at term.
Detailed Description
Research Protocol Study Design: Randomized Control Trial This is a randomized control trial comparing the usefulness of impedance cardiography (ICG) directed therapy in treating severe range hyperten...
Eligibility Criteria
Inclusion
- Patients presenting to Labor and Delivery at Cabell Huntington Hospital being treated for severe range blood pressure after 20 weeks gestation. Patients will be English speaking and range in ages from 15-45 years old. Patient's will be consented prior to randomization.
Exclusion
- Patients presenting to Labor and Delivery at Cabell Huntington Hospital with normal range blood pressures, or those with elevated blood pressures who do not consent to the study, patients \<20 weeks gestation, or patients with eclampsia.
Key Trial Info
Start Date :
April 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04748107
Start Date
April 25 2021
End Date
June 1 2023
Last Update
June 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabell Huntington Hospital
Huntington, West Virginia, United States, 25701